|
⚲
|
| Amgen Inc | |
|---|---|
| Ticker | AMGN |
| CIK # | 0000318154 |
| CUSIP | 031162100 |
| Sector | Life Sciences |
| Industry | Biological Products, (No Disgnostic Substances) |
| Phone | 8053131762 |
| Address | One Amgen Center Drive Mail Stop 24-1-B Thousand Oaks, CA 91320-1799 |
| Source | [EDGAR] |
| Market Cap, 13F ($) |
|---|
| Business |
|---|
|
Amgen Inc. (including its subsidiaries, referred to as "Amgen," "the Company," "we," "our" or "us") is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. We have a presence in approximately 100 countries worldwide. Amgen operates in one business segment: human therapeutics. |
| CIK | Filing | 2011 - 2023 |
|---|---|---|
| [0000318154] | 10-K | |
| [0000318154] | 10-Q | |
| [0000318154] | 3 | |
| [0000318154] | 4 | |
| [0000318154] | 5 | |
| [0000318154] | 8-K | |
| [0000318154] | SC 13D | |
| [0000318154] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Amgen Inc | Newamsterdam Pharma Co NV | [2022-12-02] | 9.0 |
| Amgen Inc | Vigil Neuroscience Inc | [2022-01-12] | 9.0 |
| Amgen Inc | Jasper Therapeutics Inc | [2021-10-01] | 9.0 |
| State Street Corp | Amgen Inc | [2021-02-05] | 5.17 |
| Amgen Inc | Akero Therapeutics Inc | [2020-02-10] | 9.0 |
| Amgen Inc | BeiGene Ltd | [2020-01-08] | 20.5 |
| Amgen Inc | Provention Bio Inc | [2019-09-25] | 9.0 |
| Amgen Inc | Kezar Life Sciences Inc | [2019-02-08] | 9.0 |
| FMR LLC | Amgen Inc | [2017-02-14] | 0.0 |
| Amgen Inc | Advaxis Inc | [2016-08-02] | 9.0 |
| Amgen Inc | Unilife Corp | [2016-03-03] | 9.0 |
| Amgen Inc | Atara Biotherapeutics Inc | [2015-04-01] | 9.0 |
| Vanguard Group Inc | Amgen Inc | [2015-02-11] | 5.37 |
| Amgen Inc | Cytokinetics Inc | [2013-06-18] | 7.58 |
| Capital Research Global Investors | Amgen Inc | [2013-02-12] | 8.2 |
| FMR LLC | Amgen Inc | [2012-02-14] | 0.0 |
| Amgen Inc | Micromet Inc | [2012-02-03] | 13.2 |